TESAMORELIN
NewPrice range: $89.00 through $249.00
AUDBuy TESAMORELIN Australia
A modified GHRH analogue developed for investigating growth hormone-releasing hormone receptor signalling and neuroendocrine regulation.
Out of Stock
RESEARCH USE ONLY
AMINOSPX products are supplied exclusively for legitimate laboratory, analytical, scientific and in vitro research purposes and are not intended for human or animal consumption.
Overview
Tesamorelin is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH), designed as a research model for investigating GHRH receptor biology, peptide stability and neuroendocrine signalling.
By preserving the full GRF (1–44) sequence while incorporating an N-terminal trans-3-hexenoyl modification, Tesamorelin provides researchers with a defined peptide model for exploring how targeted structural modifications influence receptor interaction and molecular stability.
Aminospx supplies Tesamorelin exclusively for legitimate laboratory, analytical, scientific and in vitro research purposes.
Not intended for human consumption or for medical, therapeutic, diagnostic, veterinary, cosmetic or food use.
Molecular Profile
- Molecular Name
- Tesamorelin
- Chemical Classification
- Synthetic Growth Hormone-Releasing Factor (GRF 1–44) Analogue
- Molecular Formula
- C221H366N72O67S
- Molecular Weight
- 5135.8 g/mol
- Length
- 44 Amino Acids
- CAS
- 218949-48-5
- PubChem CID
- 16137828
- Form
- Lyophilised Powder
- Color
- White
- Purity
- >99% HPLC
- Verification
- Third-Party Laboratory Tested
- Packaging
- Sterile Vial
Research Applications
Tesamorelin is studied in laboratory and in-vitro research across several areas of scientific interest, including:
GHRH Receptor Signalling
Used to investigate activation of the growth hormone-releasing hormone receptor.
GH Signalling Research
Studied as an experimental model of GHRH-mediated GH signalling.
GH/IGF-1 Axis Research
Used to investigate downstream IGF-1-associated signalling following GHRH receptor activation.
Endocrine Regulation Research
Studied in laboratory models involving hypothalamic-pituitary signalling.
Research Disclaimer
Information provided on this page is supplied solely for laboratory, analytical, scientific and in vitro research purposes. Products are not intended for human or veterinary use, and the information provided does not constitute medical, pharmaceutical, healthcare or other professional advice.
Nothing contained on this website should be interpreted as a recommendation regarding the diagnosis, treatment, prevention or management of any disease, condition or health outcome.
Researchers are responsible for determining the suitability of products for their intended laboratory applications and for ensuring compliance with all applicable laws, regulations and institutional requirements.
Storage & Handling
Appropriate storage and laboratory handling help maintain product integrity and research consistency.
Storage Recommendations
- Store the lyophilised compound sealed and dry below 25°C.
- Once reconstituted, store at 2–8°C in accordance with the applicable laboratory research protocol.
- Minimise repeated freeze-thaw cycles.
- Protect from heat, moisture and direct light.
Handling Recommendations
- Use appropriate laboratory personal protective equipment (PPE).
- Follow recognised laboratory procedures appropriate to the intended research application.
- Avoid contact with eyes or skin, and avoid inhalation or ingestion.
- Maintain appropriate product identification and laboratory documentation.
- Dispose of unused material according to institutional procedures and applicable regulations.
Certificate of Analysis (COA)
Important Information
Certificates of Analysis are obtained through independent third-party analytical laboratories and provided for research and informational purposes only.
Compounds tested are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic or clinical applications.
Results should be interpreted by qualified professionals within the scope of the intended research and should not be considered a guarantee of suitability for any particular application.
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a synthetic 44-amino-acid analogue of Growth Hormone-Releasing Hormone incorporating a targeted N-terminal modification. Its structure provides researchers with a defined system for examining GHRH receptor interaction, peptide stability and neuroendocrine signalling.
What strengths of Tesamorelin are available?
Aminospx Tesamorelin is available in 10 mg and 20 mg variants. Select the required strength from the product options before adding the product to your cart.
What research areas is Tesamorelin associated with?
Tesamorelin is investigated in experimental systems examining GHRH receptor activity, GH signalling, downstream GH/IGF-1 pathways and hypothalamic-pituitary communication. Its modified structure also allows researchers to examine how targeted peptide modifications influence receptor interaction and molecular stability.
How should Tesamorelin be stored?
The lyophilised material should be stored in a sealed, dry environment below 25°C. Where laboratory reconstitution is undertaken, store reconstituted material at 2–8°C. Avoid freeze–thaw cycles to help preserve product integrity.
Customer Reviews
Be the first to leave a review
Share your experience with this product and help other researchers make informed decisions.
Share your experience with this product.
